A variety of systemic inflammatory rheumatic diseases associate with an increased risk of
atherosclerotic events and premature cardiovascular (CV) disease. Although this recognition …

Objective To determine trends in survival among adult and paediatric patients with systemic
lupus erythematosus (SLE) from 1950 to the present. Methods We performed a systematic …

Risk for atherosclerotic cardiovascular disease (ASCVD) shows considerable heterogeneity
both in generally healthy persons and in those with known ASCVD. The foundation of …

Introduction: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease
characterized by organ damage, flare-remission pattern, and increased mortality when …

Background This study aimed to define the causes and associated risks of death compared
with the local general population in Chinese patients with lupus nephritis in the recent era …

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with manifold
clinical manifestations and immunological abnormalities, affecting primarily women …

In 1997, the first consensus guidelines for haematopoietic SCT (HSCT) in autoimmune
diseases (ADs) were published, while an international coordinated clinical programme was …

Heightened rates of both cardiovascular (CV) events and subclinical atherosclerosis,
documented by imaging and vascular function techniques are well established in systemic …

Both systemic lupus erythematosus (SLE) and its treatments can contribute to increased
mortality rates. The focus of this review is recent studies on mortality and comorbidities …

Objective To assess the mortality profile of systemic lupus erythematosus (SLE) patients in
France using multiple‐cause‐of‐death analysis. Methods Data were collected between …